DeepMed Research

St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Phase 2

Recruiting

Conditions: Rhabdomyosarcoma

Interventions: Drug: Vincristine
Drug: Dactinomycin
Drug: Cyclophosphamide
Procedure: Surgical Resection
Procedure: Proton beam radiation or external beam radiation or brachytherapy
Drug: Liposomal irinotecan
Drug: Vinorelbine
Drug: Temozolomide
Drug: Filgrastim, peg-filgrastim

First Posted Date: 2023-09-05

Last Posted Date: 2025-05-18

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 135

Registration Number: NCT06023641

Locations: 🇺🇸
Cook Children's Medical Center, Fort Worth, Texas, United States
🇺🇸
Sanford University, Palo Alto, California, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Writing Intervention With Adolescents and Young Adults With Cancer

Not Applicable

Recruiting

Conditions: Cancer Patients
Communication Research

Interventions: Behavioral: Writing
Behavioral: Interview

First Posted Date: 2023-08-03

Last Posted Date: 2025-03-07

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 26

Registration Number: NCT05975333

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics

Not Applicable

Recruiting

Conditions: Vaping
Vaping Cessation

First Posted Date: 2023-08-01

Last Posted Date: 2024-08-27

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 500

Registration Number: NCT05967585

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Venetoclax
Drug: Azacitidine
Drug: Cytarabine
Drug: Gemtuzumab Ozogamicin
Drug: Daunorubicin Hydrochloride
Drug: Idarubicin Hydrochloride
Drug: Fludarabine Phosphate
Drug: Mitoxantrone Hydrochloride
Drug: Etoposide
Drug: Gilteritinib

First Posted Date: 2023-07-21

Last Posted Date: 2025-01-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 70

Registration Number: NCT05955261

Locations: 🇺🇸
Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States
🇺🇸
Valley Children's Hospital, Madera, California, United States
🇺🇸
Rady Children's Hospital-San Diego, San Diego, California, United States

and more 3 locations

Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors

Phase 1

Withdrawn

Conditions: Rhabdoid Tumor
Atypical Teratoid/Rhabdoid Tumor
CNS Tumor
Atypical Teratoid/Rhabdoid Tumor of CNS

Interventions: Drug: Idasanutlin
Drug: Selinexor

First Posted Date: 2023-07-19

Last Posted Date: 2024-03-27

Lead Sponsor: St. Jude Children's Research Hospital

Registration Number: NCT05952687

Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors

Not Applicable

Recruiting

Conditions: Brain Tumor

Interventions: Other: Cognitive training via iPad
Other: Cognitive training via virtual reality

First Posted Date: 2023-07-14

Last Posted Date: 2025-05-15

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 45

Registration Number: NCT05947045

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Liver Biopsy Following Gene Therapy For Hemophilia

Not yet recruiting

Conditions: Hemophilia A
Hemophilia B

Interventions: Procedure: Liver Biopsy

First Posted Date: 2023-07-06

Last Posted Date: 2025-04-18

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 8

Registration Number: NCT05932914

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With Sepsis

Not Applicable

Recruiting

Conditions: Cardiovascular Shock
Sepsis
Acute Respiratory Distress Syndrome

Interventions: Diagnostic Test: Cardiac MRI

First Posted Date: 2023-07-05

Last Posted Date: 2025-02-12

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 20

Registration Number: NCT05930418

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

Recruiting

Conditions: Genetic Predisposition

First Posted Date: 2023-05-08

Last Posted Date: 2025-02-12

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 125

Registration Number: NCT05849155

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Phase 1

Recruiting

Conditions: Central Nervous System Neoplasms
Atypical Teratoid/Rhabdoid Tumor
Diffuse Midline Glioma, H3 K27M-Mutant
Medulloblastoma
Glioblastoma
Ependymoma
High Grade Glioma

Interventions: Drug: B7-H3-CAR T cells

First Posted Date: 2023-04-28

Last Posted Date: 2025-04-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 36

Registration Number: NCT05835687

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy